Bionano Genomics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
11.8M
on 2026-06-30, from 959K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-60 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$9.9M
H.C. Wainwright, agreement of 2025-02-21. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
12.08M
Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $13.22. 10-Q ↗
Cash
1.9 quarters
$9.9M on 2026-06-30 ÷ $5.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-09-16 | Public offering incl. 0.07M pre-funded, with warrants at $2.00 | 5,000,000 | $2.00 | $10.0M | 424B4 ↗ |
| 2025-01-03 | Registered direct offering incl. 16.78M pre-funded, with warrants at $0.25 | 39,682,540 | $0.252 | $10.0M | 424B5 ↗ |
| 2025-01-03 | Registered direct offering incl. 16.78M pre-funded | 39,682,540 | not read | $10.0M | 8-K ↗ |